Is patient-centred trial design becoming a strategic advantage for mid-size pharma, helping cut risk, improve timelines, and engage patients?
The Trump administration's long-promised direct-to-consumer (DTC) sales channel for medicines, TrumpRx, has finally gone live.
A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.
The UK confirms that the cost of the drug pricing deal with the US, initially around £1bn over three years, will be borne by the health department.
Families of young people with cancer in England will have the costs of travelling to medical appointments covered under a new funding scheme.
Editor's Picks
